Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert®): about one case and review of the therapeutic arsenal

Samuel Michael Lipski; Georges Casimir; Martine Vanlommel; Mathieu Jeanmaire; Pierre Dolhen

doi:10.1002/ccr3.171

Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert®): about one case and review of the therapeutic arsenal

Clin Case Rep. 2015 Feb;3(2):126-30. doi: 10.1002/ccr3.171. Epub 2014 Dec 5.

Authors

Samuel Michael Lipski¹, Georges Casimir², Martine Vanlommel¹, Mathieu Jeanmaire³, Pierre Dolhen¹

Affiliations

¹ Ear-Nose-Throat Department, Tivoli University Hospital, Free University of Brussels Brussels, Belgium.
² Pulmonology and Allergology Unit, University Children's Hospital Queen Fabiola, Free University of Brussels Brussels, Belgium.
³ Emergency Department, Tivoli University Hospital, Free University of Brussels Brussels, Belgium.

Abstract

C1 esterase inhibitor (Berinert®) is generally used to treat severe attack of hereditary angioedema. We describe here the case of a patient who presented with a severe angioedema induced by angiotensin-converting enzyme inhibitors (ACEIs) endangering her life. It could be successfully treated with that medicine.

Keywords: Angioedema; C1 esterase inhibitor; angiotensin-converting enzyme inhibitors; treatment; upper airways.

Publication types

Case Reports